Development of Novel Jak3 Inhibitors for the Treatment of Autoimmunity (DPFS) (Joint with University of Glasgow and Harvard University)

Project Details

StatusFinished
Effective start/end date1/02/16 → 31/03/18

Funding

  • Medical Research Council (MR/M025233/1): £283,528.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint

  • Generation of a chemical genetic model for JAK3

    Remenyi, J., Naik, R. J., Wang, J., Razsolkov, M., Verano, A., Cai, Q., Tan, L., Toth, R., Raggett, S., Baillie, C., Traynor, R., Hastie, J., Gray, N. S. & Arthur, S. C. (Lead / Corresponding author), Dec 2021, In: Scientific Reports. 11, 1, 13 p., 10093.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    5 Citations (Scopus)
    88 Downloads (Pure)